Sjögren's syndrome. Proposed criteria for classification
Robert I. Fox(Scripps Health), Francis V. Howelly(Scripps Health), Franklin Kozin(Scripps Health), Charles A. Robinson(Roche (Switzerland)), John G. Curd(Scripps Health)
Cited by 685
Related Papers
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
|The Lancet|1997|501
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
|New England Journal of Medicine|1999|485
A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis
|New England Journal of Medicine|2002|394
Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients
|Antimicrobial Agents and Chemotherapy|2000|363
Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice.
|The Journal of Experimental Medicine|1990|153